The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 15, 2022
Filed:
Jun. 21, 2016
Applicant:
Septeos, Paris, FR;
Inventor:
Nicolas Tesse, Vaucresson, FR;
Assignee:
SEPTEOS, Paris, FR;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/11 (2006.01); A61K 31/045 (2006.01); A61K 45/06 (2006.01); A61K 31/235 (2006.01); A61K 31/222 (2006.01); A61K 31/352 (2006.01); A61K 31/015 (2006.01); A61K 47/02 (2006.01); A61K 9/06 (2006.01); A61K 31/22 (2006.01); A61K 9/00 (2006.01); A61K 31/06 (2006.01); A61K 47/26 (2006.01); A61K 31/08 (2006.01); A61K 31/37 (2006.01); A61K 47/10 (2017.01); A61K 47/32 (2006.01); A61K 31/04 (2006.01); A01N 27/00 (2006.01); A01N 31/02 (2006.01); A01N 37/02 (2006.01); A01N 37/10 (2006.01); A01N 43/90 (2006.01);
U.S. Cl.
CPC ...
A61K 31/11 (2013.01); A01N 27/00 (2013.01); A01N 31/02 (2013.01); A01N 37/02 (2013.01); A01N 37/10 (2013.01); A01N 43/90 (2013.01); A61K 9/0019 (2013.01); A61K 9/0034 (2013.01); A61K 9/06 (2013.01); A61K 31/015 (2013.01); A61K 31/04 (2013.01); A61K 31/045 (2013.01); A61K 31/06 (2013.01); A61K 31/08 (2013.01); A61K 31/22 (2013.01); A61K 31/222 (2013.01); A61K 31/235 (2013.01); A61K 31/352 (2013.01); A61K 31/37 (2013.01); A61K 45/06 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01); Y02A 50/30 (2018.01);
Abstract
This invention pertains to an anti-microbial, in particular anti-bacterial, more particularly against Gram negative bacteria, and/or anti-fungal composition comprising as active blend trans-cinnamaldehyde and a potentiating agent. In particular this composition is intended for preventing and/or treating microbial infection in an animal.